Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue
disease. Once considered an untreatable and unpredictable condition, research advancements
have improved our understanding of its disease pathogenesis and clinical phenotypes
and expanded our treatment armamentarium. Early and accurate diagnosis is essential,
while ongoing efforts to risk stratify patients have a central role in predicting
both organ involvement and disease progression. A holistic approach is required when
choosing the optimal therapeutic strategy, balancing the side-effect profile with
efficacy and tailoring the treatment according to the goals of care of the patient.
Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Online mental health intervention improves anxiety in isolated scleroderma patients during the pandemic
People with a rare autoimmune disease, who likely experience more serious isolation during a global pandemic, saw their anxiety and depression improve after receiving online mental health intervention through an international study involving investigators from Michigan Medicine.
The paper, published in the
Lancet Rheumatology, analyzed the mental health progress of over 150 people with scleroderma, a disease that causes tightening of the skin and connective tissues. Researchers randomized patients to either receive video support intervention or be put on a waitlist, finding mental health outcomes improved after the program finished.
Online mental health therapy significantly aids the isolated, immunosuppressed in pandemic eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Fatigue and Raynaud’s syndrome were rated “important” or “very important” as barriers to physical activity in at least 50% of patients with systemic sclerosis, according to survey results published in
Arthritis Care & Research.
“Being physically active is important for everybody, but it is difficult for people with scleroderma who face major barriers because of their disease,”
Sami Harb, BSc, of McGill University and the Sir Mortimer B. Davis Jewish General Hospital, in Montreal, Canada, told